- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07749690
Mental Rotation and Motor Imagery Training in Multiple Sclerosis
5 août 2026 mis à jour par: Ramazan KURUL, Abant Izzet Baysal University
Mental Rotation and Motor Imagery Training for Upper-Extremity Function in Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial
This randomized controlled trial investigated the effects of sequential laterality, motor imagery, and mental rotation training in individuals with relapsing-remitting multiple sclerosis.
Both groups received conventional physiotherapy, while the intervention group received structured cognitive-motor training and the control group received active visual-attention training.
Aperçu de l'étude
Statut
Complété
Les conditions
Description détaillée
Fifty-four participants were randomly assigned to the intervention or control group.
Both groups received 45-minute sessions three times per week for six weeks.
Mental rotation ability was the primary outcome, while upper-extremity function, manual ability, motor imagery, grip strength, dexterity, and information-processing speed were assessed as secondary outcomes.
Assessments were performed before and after the intervention by a researcher blinded to group allocation.
Type d'étude
Interventionnel
Inscription (Réel)
54
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Bolu, Turquie (Türkiye), 14100
- Abant Izzet Baysal University Faculty of Health Science
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Diagnosed with definite relapsing-remitting multiple sclerosis by a neurologist according to the revised McDonald criteria
- Not experiencing an acute MS relapse
- Mini Mental State Examination score ≥24
- No clinical MS relapse within the previous 3 months
- No corticosteroid treatment for an MS relapse within the previous 3 months
- Expanded Disability Status Scale score between 1.5 and 6.0
- Modified Ashworth Scale score ≤2
- Sufficient communication ability to understand visual and verbal instructions and follow the training protocol
- Able to attend at least 80% of the planned sessions
- Able to complete the Movement Imagery Questionnaire-3
Exclusion Criteria:
- Any medication change within the previous 3 months
- Uncorrected severe visual or hearing impairment
- A communication disorder preventing the perception of or response to the visual and verbal stimuli used in the study
- Participation in another structured upper-extremity rehabilitation program or interventional study during the study period
- Presence of an additional neurological disorder
- Advanced sensory loss or proprioceptive impairment that could affect participation in the intervention
- Botulinum toxin injection within the previous 3 months
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Multicomponent rotation training
Participants received 30 minutes of conventional physiotherapy and 15 minutes of sequential laterality, motor imagery, and mental rotation training, three times per week for six weeks.
|
Participants received 30 minutes of conventional physiotherapy followed by 15 minutes of structured training, three times per week for six weeks.
The training progressed sequentially through laterality recognition, motor imagery, and mental rotation.
Laterality training involved identifying right- and left-hand images.
Motor imagery training involved imagining the hand positions and movements shown in the images without performing an observable movement.
Mental rotation training involved mentally rotating figures and selecting the correct response.
|
|
Comparateur factice: Sham training
Participants received 30 minutes of conventional physiotherapy and 15 minutes of active visual-attention training using neutral objects, colors, shapes, and symbols, three times per week for six weeks.
|
Participants received 30 minutes of conventional physiotherapy followed by 15 minutes of active visual-attention control training, three times per week for six weeks.
The training included images of neutral objects, colors, geometric shapes, and symbols that did not depict body parts.
Participants classified the images according to color, shape, size, position, or similarity and difference.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The Purdue Spatial Visualization Test
Délai: Baseline and immediately after the 6-week intervention.
|
The Purdue Spatial Visualization Test a widely used mental rotation tests, consists of 30 three-dimensional spatial perception questions.
|
Baseline and immediately after the 6-week intervention.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The Symbol Digit Modalities Test
Délai: Baseline and immediately after the 6-week intervention.
|
The Symbol Digit Modalities Test is a widely used assessment tool for measuring information-processing speed in patients with MS.
|
Baseline and immediately after the 6-week intervention.
|
|
Nine-Hole Peg Test
Délai: Baseline and immediately after the 6-week intervention.
|
In the Nine-Hole Peg Test, nine wooden pegs were placed into a wooden board containing nine holes using one hand.
|
Baseline and immediately after the 6-week intervention.
|
|
Kinesthetic and Visual Imagery Questionnaire
Délai: Baseline and immediately after the 6-week intervention.
|
Motor imagery ability was evaluated and scored using 20 items examining movements of different body parts in a sitting position, with two subscales assessing kinesthetic and visual imagery abilities.
The total score ranges from 10 to 50, with each subscale ranging from 5 to 25.
|
Baseline and immediately after the 6-week intervention.
|
|
Grip Strength
Délai: Baseline and immediately after the 6-week intervention
|
Grip strength was assessed using a Jamar hand dynamometer.
|
Baseline and immediately after the 6-week intervention
|
|
Abilhand
Délai: Baseline and immediately after the 6-week intervention.
|
Abilhand is a patient-reported scale used to determine the perceived level of difficulty individuals experience when using their hands during activities of daily living.
The Abilhand total raw score ranges from 0 to 46, with higher scores indicating better self-perceived manual ability in performing daily bimanual activities.
|
Baseline and immediately after the 6-week intervention.
|
|
The Action Research Arm Test (ARAT)
Délai: Baseline and immediately after the 6-week intervention.
|
The Action Research Arm Test was used to evaluate upper extremity functional capacity and consists of four subdomains: grasp, grip, pinch, and gross movement.
|
Baseline and immediately after the 6-week intervention.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Enes Tayyip Benli, phd, Abant Izzet Baysal University
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
15 février 2024
Achèvement primaire (Réel)
15 janvier 2026
Achèvement de l'étude (Réel)
15 février 2026
Dates d'inscription aux études
Première soumission
30 juillet 2026
Première soumission répondant aux critères de contrôle qualité
5 août 2026
Première publication (Réel)
6 août 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
6 août 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
5 août 2026
Dernière vérification
1 août 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AIBU-FTR-BENLI-010
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .